In relation to cancer progression, LRP5 has been shown to be involved in mediating Wnt/β-catenin signaling in skeletal metastasis prostate cancer (PC) due to the increased level of Wnt-1 and β-catenin proteins in both PC cell lines and primary specimens [19]. This evidence concerns the gene LRP5 and cancer.